ery

Generic: erythromycin

Labeler: padagis israel pharmaceuticals ltd
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ery
Generic Name erythromycin
Labeler padagis israel pharmaceuticals ltd
Dosage Form SWAB
Routes
TOPICAL
Active Ingredients

erythromycin 20 mg/mL

Manufacturer
Padagis Israel Pharmaceuticals Ltd

Identifiers & Regulatory

Product NDC 45802-962
Product ID 45802-962_02f703fe-50b5-45dc-bfbb-fb0ef4784bcc
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA064126
Listing Expiration 2026-12-31
Marketing Start 2008-07-07

Pharmacologic Class

Established (EPC)
macrolide [epc] macrolide antimicrobial [epc]
Chemical Structure
macrolides [cs]
Physiologic Effect
decreased sebaceous gland activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 45802962
Hyphenated Format 45802-962

Supplemental Identifiers

RxCUI
797452 798133
UPC
0345802962720
UNII
63937KV33D
NUI
N0000009982 N0000175877 N0000175935 M0028311

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ery (source: ndc)
Generic Name erythromycin (source: ndc)
Application Number ANDA064126 (source: ndc)
Routes
TOPICAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/mL
source: ndc
Packaging
  • 60 APPLICATOR in 1 JAR (45802-962-72) / .8 mL in 1 APPLICATOR
source: ndc

Packages (1)

Ingredients (1)

erythromycin (20 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["TOPICAL"], "spl_id": "02f703fe-50b5-45dc-bfbb-fb0ef4784bcc", "openfda": {"nui": ["N0000009982", "N0000175877", "N0000175935", "M0028311"], "upc": ["0345802962720"], "unii": ["63937KV33D"], "rxcui": ["797452", "798133"], "spl_set_id": ["9a63da11-01be-4c63-a260-e6bdbb4a7a69"], "pharm_class_cs": ["Macrolides [CS]"], "pharm_class_pe": ["Decreased Sebaceous Gland Activity [PE]"], "pharm_class_epc": ["Macrolide [EPC]", "Macrolide Antimicrobial [EPC]"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 APPLICATOR in 1 JAR (45802-962-72)  / .8 mL in 1 APPLICATOR", "package_ndc": "45802-962-72", "marketing_start_date": "20080707"}], "brand_name": "Ery", "product_id": "45802-962_02f703fe-50b5-45dc-bfbb-fb0ef4784bcc", "dosage_form": "SWAB", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Macrolide Antimicrobial [EPC]", "Macrolide [EPC]", "Macrolides [CS]"], "product_ndc": "45802-962", "generic_name": "Erythromycin", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ery", "active_ingredients": [{"name": "ERYTHROMYCIN", "strength": "20 mg/mL"}], "application_number": "ANDA064126", "marketing_category": "ANDA", "marketing_start_date": "20080707", "listing_expiration_date": "20261231"}